TITLE

Codelivery of Nanosized Curcumin and Bioenhancer using Acid Degradable Polymeric Nanoparticles Displayed Enhanced Anticancer Efficacy

AUTHOR(S)
Chidambaram, Moorthi; Krishnasamy, Kathiresan
PUB. DATE
April 2014
SOURCE
Nano Biomedicine & Engineering;2014, Vol. 6 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Curcumin, a functional food polyphenol reported to inhibit cancer cell proliferation, invasion, angiogenesis and metastasis through interaction with multiple molecular targets. However, the clinical usefulness of curcumin in the treatment of cancer is limited due to poor solubility in water at acidic and neutral pH, hydrolytic degradation in alkaline pH and metabolism in the liver and intestine, resulting in decreased or absence of therapeutic efficacy. Hence, the present study was aimed to overcome the limitations of curcumin in the treatment of cancer by codelivery of nanosized curcumin and bioenhancer using acid degradable polymeric nanoparticles. Modified nanoprecipitation method was used to prepare void, curcumin-piperine, curcumin-quercetin and curcumin-silibinin encapsulated polymeric nanoparticles. Prepared nanoformulations were evaluated for particle size, polydispersity index, zeta potential, surface morphology, drug content, encapsulation efficiency, drug loading, in-vitro release, stability at elevated storage conditions, toxicity on normal liver cells, anticancer activity on various cancer cell lines and on cancer induced rats. Prepared curcumin-bioenhancer encapsulated polymeric nanoparticles were (a) spherical in shape with size <100 nm and displayed excellent uniformity; (b) showed >95% release of curcumin and bioenhancers within 45 minutes in gastric fluid; (c) proved non-toxic to normal liver cells; (d) extremely stable at elevated storage conditions; and (e) demonstrated enhanced anticancer activity against various cancer cell lines and mammary cancer in rats than the pure curcumin. Study concludes that the prepared curcumin-bioenhancer encapsulated polymeric nanoformulations significantly overcome the limitations of curcumin in the treatment of cancer and synergistically enhance its anticancer activity. However, out of three polymeric nanoformulations, curcumin-silibinin polymeric nanoformulation showed superior anticancer activity.
ACCESSION #
97112563

 

Related Articles

  • The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells. Hallman, Kelly; Aleck, Katie; Dwyer, Brigitte; Lloyd, Victoria; Quigley, Meghan; Sitto, Nada; Siebert, Amy E.; Dinda, Sumi // Breast Cancer: Targets & Therapy;Mar2017, Vol. 9, p153 

    Curcumin (CUR) is a compound that has antibacterial, antiviral, anti-inflammatory, and anticancer properties. In this study, we have analyzed the effects of CUR on the expression of ERa and p53 in the presence of hormones and anti-hormones in breast cancer cells. Cells were cultured in a medium...

  • Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles. Sun, Qing; Li, Weifeng; Li, Huani; Wang, Xiumei; Wang, Yu; Niu, Xiaofeng // Pharmacology;May2017, Vol. 100 Issue 1/2, p14 

    Aim: This study was designed to develop sanguinarine-loaded solid lipid nanoparticles (SG-SLNs) and investigate its gastroprotective effect on ethanol-induced gastric mucosal lesions in mice. Methods: SG-SLNs were prepared by high temperature melt-cool solidification method using glycerol...

  • Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Green, Ralph // American Journal of Clinical Nutrition;Aug2011, Vol. 94 Issue 2, p666S 

    Deficiencies of folate or of vitamin B-12 are widespread and constitute a major global burden of morbidity that affect all age groups. Detecting or confirming the presence of folate or vitamin B-12 deficiency and distinguishing one from the other depends, ultimately, on laboratory testing. Tests...

  • Herbal nanoparticles: A patent review. Jadhav, Namdeo R.; Powar, Trupti; Shinde, Santosh; Nadaf, Sameer // Asian Journal of Pharmaceutics (Medknow Publications & Media Pvt;Jan-Mar2014, Vol. 8 Issue 1, p58 

    Design and development of herbal nanoparticles has become a frontier research in the nanoformulation arena. To update researchers, an attempt has been made to review nanoformulation-based herbal patents. This article mainly covers herbal medicines are used for the treatment of cardiovascular...

  • Rosiglitazone and diabetic macular oedema.  // WHO Drug Information;2006, Vol. 20 Issue 1, p12 

    The article discusses the efficacy of the drug rosiglitazone for the treatment of diabetic macular oedema in the U.S. The U.S. Food and Drug Administration found that the patients treated with rosiglitazone reported concurrent peripheral oedema. In some cases, the discontinuation of therapy...

  • Efficacy and Safety of Micafungin as an Empirical Antifungal Agent for Febrile Neutropenic Patients with Hematological Diseases. Joon Seong Park; Dong Hwan Kim; Chul Won Choi; Seong Hyun Jeong; Jin-Hyuk Choi; Kihyun Kim; Seok Jin Kim; Chul Won Jung; Deok-Hwan Yang; Jun Ho Jang // Acta Haematologica;Oct2010, Vol. 124 Issue 2, p92 

    Background: This observational study was conducted to document the efficacy and safety of the use of micafungin (Mycamine) as an empirical antifungal agent in febrile neutropenic patients. Methods: Micafungin was administered for sustained fever (>38.4°C) on days 3-5 following the initiation...

  • Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Peuskens, J. // British Journal of Psychiatry;Jun95, Vol. 166, p712 

    Background: This study was performed in order to evaluate the short-term efficacy and safety of fixed risperidone doses compared to haloperidol.Method: In a multi-national, parallel-group, double-blind study, patients with chronic schizophrenia (DSM-III-R) were randomly...

  • Sirtuin 3 silencing improves oxaliplatin efficacy through acetylation of MnSOD in colon cancer. Torrens‐Mas, Margalida; Hernández‐López, Reyniel; Oliver, Jordi; Roca, Pilar; Sastre‐Serra, Jorge // Journal of Cellular Physiology;Aug2018, Vol. 233 Issue 8, p6067 

    Sirtuin 3 (SIRT3) is the major mitochondria deacetylase and regulates ROS levels by targeting several key proteins, such as those involved in mitochondrial function and antioxidant defenses. This way, SIRT3 balances ROS production and scavenging and promotes cell survival. The aim of this study...

  • A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer. Kumar, Bhavna; Yadav, Arti; Hideg, Kalman; Kuppusamy, Periannan; Teknos, Theodoros N.; Kumar, Pawan // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Chemotherapy constitutes the standard modality of treatment for localized head and neck squamous cell carcinomas (HNSCC). However, many patients fail to respond and relapse after this treatments due to the acquisition of chemo-resistance. Therefore, there is an urgent need to develop novel drugs...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics